What is Alio?
Alio is addressing a critical gap in remote patient monitoring by developing advanced technology that overcomes the limitations of current tools. Existing solutions are often invasive, costly, and yield insufficient data, leading to poor patient compliance. Alio's approach leverages off-the-shelf sensors and integrates data from various sources, including fitness trackers, to produce clinical-grade, accurate data. This aggregated information is then transformed into actionable insights, offering a superior user experience and enhanced data reliability. While initially conceived for diverse healthcare settings, Alio's innovative technology demonstrates broad applicability across multiple industries, positioning it as a versatile solution provider.
How much funding has Alio raised?
Alio has raised a total of $49M across 3 funding rounds:
Series A
$11M
Series B
$20M
Series C
$18M
Series A (2018): $11M, investors not publicly disclosed
Series B (2021): $20M led by Thomas Krebs and Zekavat Investment Group
Series C (2022): $18M supported by LLC, Chase Field, and Widjaja Family Investment Office
Key Investors in Alio
Chase Field
Chase Field, associated with www.cactusbowl2017.com, likely focuses on strategic investments with a broad industry scope, potentially including technology and growth-stage companies.
Zekavat Investment Group
Zekavat Investment Group, operating at zekavatgroup.com, is presumed to be a venture capital firm or investment entity that supports companies with innovative technologies and scalable business models.
What's next for Alio?
The recent major strategic investment signals a pivotal moment for Alio, likely enabling the company to accelerate its product development, scale its operations, and expand its market reach. This infusion of capital suggests a transition into a growth or scaling phase, where strategic partnerships and market penetration will be key. Alio is poised to further solidify its position by enhancing its data analytics capabilities and potentially exploring new industry verticals where its remote monitoring technology can offer significant value. The company's focus on clinical-grade data and user experience positions it for sustained competitive advantage.
See full Alio company page
